Cargando…

Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing

BACKGROUND: Germ-line mutations of BRCA1 and BRCA2 genes are responsible for approximately 25–30% of dominantly inherited familial breast cancers; still a big part of genetic component is unknown. The aim of this study was to investigate genetic causes of familial breast cancer in a pedigree with re...

Descripción completa

Detalles Bibliográficos
Autores principales: ATAEI-KACHOUEI, Mojgan, NADAF, Javad, AKBARI, Mohammad Taghi, ATRI, Morteza, MAJEWSKI, Jacek, RIAZALHOSSEINI, Yasser, GARSHASBI, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644579/
https://www.ncbi.nlm.nih.gov/pubmed/26576347
_version_ 1782400677875548160
author ATAEI-KACHOUEI, Mojgan
NADAF, Javad
AKBARI, Mohammad Taghi
ATRI, Morteza
MAJEWSKI, Jacek
RIAZALHOSSEINI, Yasser
GARSHASBI, Masoud
author_facet ATAEI-KACHOUEI, Mojgan
NADAF, Javad
AKBARI, Mohammad Taghi
ATRI, Morteza
MAJEWSKI, Jacek
RIAZALHOSSEINI, Yasser
GARSHASBI, Masoud
author_sort ATAEI-KACHOUEI, Mojgan
collection PubMed
description BACKGROUND: Germ-line mutations of BRCA1 and BRCA2 genes are responsible for approximately 25–30% of dominantly inherited familial breast cancers; still a big part of genetic component is unknown. The aim of this study was to investigate genetic causes of familial breast cancer in a pedigree with recessive pattern of inheritance. METHODS: We applied exome sequencing as a useful approach in heterogeneous diseases gene identification in present study for familial breast cancer. Sanger sequencing was applied for validation and segregation analysis of mutations. RESULTS: Here, we describe a family with three affected sisters of early-onset invasive ductal carcinoma due to heterozygous frame shift mutation rs80359352 in BRCA2 gene as the first report in Iranian patients in association with a novel missense SNP of STK11 (p.S422G). These mutations are inherited from their normal father. CONCLUSION: Despite apparent recessive pattern of inheritance a dominant gene (here BRCA2) can be involved in pathogenesis of hereditary breast cancer which can be explained by incomplete penetrance of BRCA2 mutations.
format Online
Article
Text
id pubmed-4644579
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-46445792015-11-16 Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing ATAEI-KACHOUEI, Mojgan NADAF, Javad AKBARI, Mohammad Taghi ATRI, Morteza MAJEWSKI, Jacek RIAZALHOSSEINI, Yasser GARSHASBI, Masoud Iran J Public Health Original Article BACKGROUND: Germ-line mutations of BRCA1 and BRCA2 genes are responsible for approximately 25–30% of dominantly inherited familial breast cancers; still a big part of genetic component is unknown. The aim of this study was to investigate genetic causes of familial breast cancer in a pedigree with recessive pattern of inheritance. METHODS: We applied exome sequencing as a useful approach in heterogeneous diseases gene identification in present study for familial breast cancer. Sanger sequencing was applied for validation and segregation analysis of mutations. RESULTS: Here, we describe a family with three affected sisters of early-onset invasive ductal carcinoma due to heterozygous frame shift mutation rs80359352 in BRCA2 gene as the first report in Iranian patients in association with a novel missense SNP of STK11 (p.S422G). These mutations are inherited from their normal father. CONCLUSION: Despite apparent recessive pattern of inheritance a dominant gene (here BRCA2) can be involved in pathogenesis of hereditary breast cancer which can be explained by incomplete penetrance of BRCA2 mutations. Tehran University of Medical Sciences 2015-10 /pmc/articles/PMC4644579/ /pubmed/26576347 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
ATAEI-KACHOUEI, Mojgan
NADAF, Javad
AKBARI, Mohammad Taghi
ATRI, Morteza
MAJEWSKI, Jacek
RIAZALHOSSEINI, Yasser
GARSHASBI, Masoud
Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title_full Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title_fullStr Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title_full_unstemmed Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title_short Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing
title_sort double heterozygosity of brca2 and stk11 in familial breast cancer detected by exome sequencing
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644579/
https://www.ncbi.nlm.nih.gov/pubmed/26576347
work_keys_str_mv AT ataeikachoueimojgan doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT nadafjavad doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT akbarimohammadtaghi doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT atrimorteza doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT majewskijacek doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT riazalhosseiniyasser doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing
AT garshasbimasoud doubleheterozygosityofbrca2andstk11infamilialbreastcancerdetectedbyexomesequencing